Christopher G. Hayes
2023
In 2023, Christopher G. Hayes earned a total compensation of $2.6M as Chief Legal Officer at Verrica Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $169,600 |
|---|---|
| Option Awards | $817,925 |
| Salary | $424,000 |
| Stock Awards | $1,137,000 |
| Other | $13,779 |
| Total | $2,561,674 |
Hayes received $1.1M in stock awards, accounting for 44% of the total pay in 2023.
Hayes also received $169.6K in non-equity incentive plan, $817.9K in option awards, $424K in salary and $13.8K in other compensation.
Rankings
In 2023, Christopher G. Hayes' compensation ranked 364th out of 2,647 executives tracked by ExecPay. In other words, Hayes earned more than 86.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 364 out of 2,647 | 86th |
Division Manufacturing | 208 out of 1,447 | 86th |
Major group Chemicals And Allied Products | 146 out of 817 | 82nd |
Industry group Drugs | 143 out of 783 | 82nd |
Industry Pharmaceutical Preparations | 86 out of 555 | 85th |
Source: SEC filing on April 19, 2024.
Hayes' colleagues
We found two more compensation records of executives who worked with Christopher G. Hayes at Verrica Pharmaceuticals in 2023.